Trials / Completed
CompletedNCT03595618
A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis
Efficacy and Safety of 3 Doses of S201086/GLPG1972 Administered Orally Once Daily in Patients With Knee Osteoarthritis. A 52-week International, Multi-regional, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 932 (actual)
- Sponsor
- Galapagos NV · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is a phase 2, 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controlled dose-ranging study for the treatment of osteoarthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GLPG1972 | Film-coated tablets of GLPG1972 for oral use. |
| DRUG | Placebo | Film-coated tablets of matching placebo for oral use. |
Timeline
- Start date
- 2018-08-14
- Primary completion
- 2020-07-14
- Completion
- 2020-07-14
- First posted
- 2018-07-23
- Last updated
- 2021-07-28
- Results posted
- 2021-05-12
Locations
44 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03595618. Inclusion in this directory is not an endorsement.